CRNX Crinetics Pharmaceuticals Inc

USD 46.81 2.38 5.356741
Icon

Crinetics Pharmaceuticals Inc (CRNX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 46.81

+2.38 (+5.36)%

USD 3.45B

1.29M

USD 53.46(+14.21%)

USD 0.00 (-100.00%)

Icon

CRNX

Crinetics Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 46.81
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 3.45B

USD 0.00 (-100.00%)

USD 46.81

Crinetics Pharmaceuticals Inc (CRNX) Stock Forecast

Show ratings and price targets of :
USD 53.46
(+14.21%)

Based on the Crinetics Pharmaceuticals Inc stock forecast from 8 analysts, the average analyst target price for Crinetics Pharmaceuticals Inc is USD 53.46 over the next 12 months. Crinetics Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Crinetics Pharmaceuticals Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Crinetics Pharmaceuticals Inc’s stock price was USD 46.81. Crinetics Pharmaceuticals Inc’s stock price has changed by +4.09% over the past week, +9.47% over the past month and +205.75% over the last year.

No recent analyst target price found for Crinetics Pharmaceuticals Inc
No recent average analyst rating found for Crinetics Pharmaceuticals Inc

Company Overview Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral sele...Read More

https://www.crinetics.com

6055 Lusk Boulevard, San Diego, CA, United States, 92121

290

December

USD

USA

Adjusted Closing Price for Crinetics Pharmaceuticals Inc (CRNX)

Loading...

Unadjusted Closing Price for Crinetics Pharmaceuticals Inc (CRNX)

Loading...

Share Trading Volume for Crinetics Pharmaceuticals Inc Shares

Loading...

Compare Performance of Crinetics Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CRNX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Crinetics Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S +0.35 (+0.27%) USD554.45B 46.01 4.80

ETFs Containing CRNX

Symbol Name CRNX's Weight Expense Ratio Price(Change) Market Cap
SURI
Simplify Propel Opportuni.. 4.07 % 2.51 % +0.11 (+0.43%) USD0.12B

Frequently Asked Questions About Crinetics Pharmaceuticals Inc (CRNX) Stock

Based on ratings from 8 analysts Crinetics Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 13 buy, sell and hold ratings.

Unfortunately we do not have enough data on CRNX's stock to indicate if its a good dividend stock.

Based on targets from 8 analysts, the average taret price for CRNX is USD 53.46 over the next 12 months. The maximum analyst target price is USD 68 while the minimum anlayst target price is USD 35.

Unfortunately we do not have enough data on CRNX's stock to indicate if its overvalued.

The last closing price of CRNX's stock was USD 46.81.

The most recent market capitalization for CRNX is USD 3.45B.

Based on targets from 8 analysts, the average taret price for CRNX is projected at USD 53.46 over the next 12 months. This means that CRNX's stock price may go up by +14.21% over the next 12 months.

Following are ETFs with the highest allocation to Crinetics Pharmaceuticals Inc's stock :

SURI

As per our most recent records Crinetics Pharmaceuticals Inc has 290 Employees.

Crinetics Pharmaceuticals Inc's registered address is 6055 Lusk Boulevard, San Diego, CA, United States, 92121. You can get more information about it from Crinetics Pharmaceuticals Inc's website at https://www.crinetics.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...